Video

Ushering in the Golden Era of Alzheimer Drug Development?

Author(s):

RJ Tesi, MD

What effect will aducanumab have on Alzheimer disease treatment?

RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.

Dr Tesi is CEO and Chief Medical Officer of INmuneBio.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
New Africa /Adobestock
Alzheimer
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
Related Content
dementia
May 6th 2025

Dementia Prevention: Pipe Dream vs Possibility

Pallavi Joshi, DO, MA Pierre N. Tariot, MD
What Will the Future of Alzheimer Disease Treatment Look Like?
July 23rd 2021

What Will the Future of Alzheimer Disease Treatment Look Like?

Helen Lavretsky, MD, MS
Parkinson disease
April 25th 2025

Depression, Apathy, and Anxiety in Parkinson Disease

Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP Sarah Snyder, MS
Site Logo
August 16th 2012

The Relevance of New Alzheimer Guidelines for Clinical Practice

Christopher Van Dyck, MD
Alzheimer
April 4th 2025

Positive Interim Results on Trontinemab Validate Brainshuttle Technology for Alzheimer Disease Treatment

Leah Kuntz
Psychiatric Times Through the Years: The Last 5 Years in March Covers
March 3rd 2025

Psychiatric Times Through the Years: The Last 5 Years in March Covers

Megan McSweeney
© 2025 MJH Life Sciences

All rights reserved.